Can a DNA construction kit replace expensive antibody medication?

September 11, 2019

Researchers at KU Leuven in Belgium have developed a technique to make sheep produce new antibodies simply by injecting the DNA building blocks. This approach is much cheaper and more efficient than producing antibodies industrially and administering them afterwards. The study in animals with a similar size as humans brings us a step closer to the clinical use of antibody gene therapy.

Antibodies are a natural and important part of our immune system. They protect us against foreign intruders in the body, such as viruses or bacteria. Additionally, in the past couple of years, researchers have been developing antibodies in the lab to use as a treatment for infectious diseases or cancer, among others. Most immune therapies, for example, use antibodies. However, their production requires industrial bioreactors that can hold tens of thousands of litres of material. It is a complicated and expensive process, and the resulting medicines can cost up to hundreds of thousands of euros per year.

A team led by Professor Kevin Hollevoet and Professor Paul Declerck of the Laboratory for Therapeutic and Diagnostic Antibodies in collaboration with Dr Nick Geukens of PharmAbs has developed a technique that enables the body itself to produce specific antibodies.

By allowing the body to take over this process,This alternative to the current industrial process can lower the price of antibody therapy drastically. Additionally, the effect of the DNA injection lasts longer, which means that patients would need fewer treatments. As a result, the new technique can increase access to expensive antibody medications.

"Just like other proteins, each antibody has a unique DNA code with building blocks and instructions," explains Hollevoet. "To get this information into the body, we put the desired code in a specially developed plasmid, which is a circular string of DNA. The plasmid functions as a vehicle for the DNA code."

The researchers inject this construction kit into the muscles, followed by a few small electric shocks, comparable to a series of pinpricks. The shocks ensure that the muscle cells can take up the DNA. Next, the cells use the instructions from the code to produce antibodies and send them into the blood, from where they can execute their therapeutic effect.

"There have been several successful studies in the past on mice, including by our research group," says Hollevoet. "But we didn't know whether this approach would work on humans, since they are much larger in size." The researchers decided to test the technique on sheep to build a bridge from the lab to the hospital. Sheep are similar to humans in terms of weight, muscle mass and blood volume. During the development and injection of the DNA construction kit, the researchers tried to mimic a clinical setting, in collaboration with Dr Stéphanie De Vleeschauwer of the KU Leuven Animal Research Center. The sheep's blood tests show that the produced antibodies were present in the body at levels that indicate they could be used as medication. Moreover, the antibodies could be detected in the blood up to almost a year after the injection.

"The fact that this technique also works in larger animals shows that this kind of treatment could be possible for humans. It's a milestone for antibody gene therapy," Declerck says. According to the researchers, sheep can also be used to test potential DNA medications to lower the risk of failure in later clinical trials.

The lab is now working with different research groups and companies to improve the technique. One of the big challenges is to select the most appropriate antibodies. "In principle, we can inject the DNA code of any antibody, but we focus on diseases where this approach can help patients the best," Hollevoet explains. "Currently, we are mostly focused on cancer treatments, among others immune therapy. We also see possibilities for infectious diseases like HIV and the flu, and neurological diseases like Alzheimer's. Even though there are still road blocks on the way to using this treatment in humans, the finish line has never been so close."
-end-
Contact

Kevin Hollevoet, Biomedical Sciences Group, Department of Pharmaceutical and Pharmacological Sciences, mobile: +32 495 99 79 64, email: kevin.hollevoet@kuleuven.be

More information

The paper "Bridging the Clinical Gap for DNA-based Antibody Therapy through Translational Studies in Sheep" by Kevin Hollevoet, Stéphanie De Vleeschauwer, Elien De Smidt, Giles Vermeire, Nick Geukens, and Paul Declerck is published in Human Gene Therapy.

This research was funded by The Research Foundation - Flanders (FWO), Flanders Innovation & Entrepreneurship and KU Leuven.

KU Leuven

Related DNA Articles from Brightsurf:

A new twist on DNA origami
A team* of scientists from ASU and Shanghai Jiao Tong University (SJTU) led by Hao Yan, ASU's Milton Glick Professor in the School of Molecular Sciences, and director of the ASU Biodesign Institute's Center for Molecular Design and Biomimetics, has just announced the creation of a new type of meta-DNA structures that will open up the fields of optoelectronics (including information storage and encryption) as well as synthetic biology.

Solving a DNA mystery
''A watched pot never boils,'' as the saying goes, but that was not the case for UC Santa Barbara researchers watching a ''pot'' of liquids formed from DNA.

Junk DNA might be really, really useful for biocomputing
When you don't understand how things work, it's not unusual to think of them as just plain old junk.

Designing DNA from scratch: Engineering the functions of micrometer-sized DNA droplets
Scientists at Tokyo Institute of Technology (Tokyo Tech) have constructed ''DNA droplets'' comprising designed DNA nanostructures.

Does DNA in the water tell us how many fish are there?
Researchers have developed a new non-invasive method to count individual fish by measuring the concentration of environmental DNA in the water, which could be applied for quantitative monitoring of aquatic ecosystems.

Zigzag DNA
How the cell organizes DNA into tightly packed chromosomes. Nature publication by Delft University of Technology and EMBL Heidelberg.

Scientists now know what DNA's chaperone looks like
Researchers have discovered the structure of the FACT protein -- a mysterious protein central to the functioning of DNA.

DNA is like everything else: it's not what you have, but how you use it
A new paradigm for reading out genetic information in DNA is described by Dr.

A new spin on DNA
For decades, researchers have chased ways to study biological machines.

From face to DNA: New method aims to improve match between DNA sample and face database
Predicting what someone's face looks like based on a DNA sample remains a hard nut to crack for science.

Read More: DNA News and DNA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.